VERISMO THERAPEUTICS Trademark
Trademark Overview
On Tuesday, July 11, 2023, a trademark application was filed for VERISMO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERISMO THERAPEUTICS trademark a serial number of 98079556. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 20, 2024. This trademark is owned by Verismo Therapeutics Inc.. The VERISMO THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
anti-cancer preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy; pharmaceutical preparations for the suppression and treatment of tumors
pharmaceutical research services; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer
General Information
| Serial Number | 98079556 |
| Word Mark | VERISMO THERAPEUTICS |
| Filing Date | Tuesday, July 11, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, March 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | anti-cancer preparations; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy; pharmaceutical preparations for the suppression and treatment of tumors |
| Goods and Services | pharmaceutical research services; research and development of pharmaceuticals for the treatment of cancer; laboratory research services relating to pharmaceuticals; medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 9, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 9, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, November 30, 2020 |
| First Use In Commerce Date | Monday, November 30, 2020 |
Trademark Owner History
| Party Name | Verismo Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19104 |
Trademark Events
| Event Date | Event Description |
| Friday, July 14, 2023 | NEW APPLICATION ENTERED |
| Wednesday, August 9, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 20, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 20, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, June 20, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, March 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 20, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 20, 2024 | NON-FINAL ACTION E-MAILED |
